Vaccine rollout strategies: The case for vaccinating essential workers early
In vaccination campaigns against COVID-19, many jurisdictions are using age-based rollout strategies, reflecting the much higher risk of severe outcomes of infection in older groups. In the wake of growing evidence that approved vaccines are effective at preventing not only adverse outcomes, but als...
Saved in:
| Published in | PLOS global public health Vol. 1; no. 10; p. e0000020 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science (PLoS)
13.10.2021
|
| Online Access | Get full text |
| ISSN | 2767-3375 2767-3375 |
| DOI | 10.1371/journal.pgph.0000020 |
Cover
| Abstract | In vaccination campaigns against COVID-19, many jurisdictions are using age-based rollout strategies, reflecting the much higher risk of severe outcomes of infection in older groups. In the wake of growing evidence that approved vaccines are effective at preventing not only adverse outcomes, but also infection, we show that such strategies are less effective than strategies that prioritize essential workers. This conclusion holds across numerous outcomes, including cases, hospitalizations, Long COVID (cases with symptoms lasting longer than 28 days), deaths and net monetary benefit. Our analysis holds in regions where the vaccine supply is limited, and rollout is prolonged for several months. In such a setting with a population of 5M, we estimate that vaccinating essential workers sooner prevents over 200,000 infections, over 600 deaths, and produces a net monetary benefit of over $500M. |
|---|---|
| AbstractList | In vaccination campaigns against COVID-19, many jurisdictions are using age-based rollout strategies, reflecting the much higher risk of severe outcomes of infection in older groups. In the wake of growing evidence that approved vaccines are effective at preventing not only adverse outcomes, but also infection, we show that such strategies are less effective than strategies that prioritize essential workers. This conclusion holds across numerous outcomes, including cases, hospitalizations, Long COVID (cases with symptoms lasting longer than 28 days), deaths and net monetary benefit. Our analysis holds in regions where the vaccine supply is limited, and rollout is prolonged for several months. In such a setting with a population of 5M, we estimate that vaccinating essential workers sooner prevents over 200,000 infections, over 600 deaths, and produces a net monetary benefit of over $500M. In vaccination campaigns against COVID-19, many jurisdictions are using age-based rollout strategies, reflecting the much higher risk of severe outcomes of infection in older groups. In the wake of growing evidence that approved vaccines are effective at preventing not only adverse outcomes, but also infection, we show that such strategies are less effective than strategies that prioritize essential workers. This conclusion holds across numerous outcomes, including cases, hospitalizations, Long COVID (cases with symptoms lasting longer than 28 days), deaths and net monetary benefit. Our analysis holds in regions where the vaccine supply is limited, and rollout is prolonged for several months. In such a setting with a population of 5M, we estimate that vaccinating essential workers sooner prevents over 200,000 infections, over 600 deaths, and produces a net monetary benefit of over $500M.In vaccination campaigns against COVID-19, many jurisdictions are using age-based rollout strategies, reflecting the much higher risk of severe outcomes of infection in older groups. In the wake of growing evidence that approved vaccines are effective at preventing not only adverse outcomes, but also infection, we show that such strategies are less effective than strategies that prioritize essential workers. This conclusion holds across numerous outcomes, including cases, hospitalizations, Long COVID (cases with symptoms lasting longer than 28 days), deaths and net monetary benefit. Our analysis holds in regions where the vaccine supply is limited, and rollout is prolonged for several months. In such a setting with a population of 5M, we estimate that vaccinating essential workers sooner prevents over 200,000 infections, over 600 deaths, and produces a net monetary benefit of over $500M. |
| Author | Kirwin, Erin Colijn, Caroline Mulberry, Nicola McCabe, Christopher Tupper, Paul |
| Author_xml | – sequence: 1 givenname: Nicola orcidid: 0000-0002-1465-8001 surname: Mulberry fullname: Mulberry, Nicola – sequence: 2 givenname: Paul orcidid: 0000-0002-4340-4481 surname: Tupper fullname: Tupper, Paul – sequence: 3 givenname: Erin orcidid: 0000-0001-6957-7236 surname: Kirwin fullname: Kirwin, Erin – sequence: 4 givenname: Christopher orcidid: 0000-0001-5728-4129 surname: McCabe fullname: McCabe, Christopher – sequence: 5 givenname: Caroline orcidid: 0000-0001-6097-6708 surname: Colijn fullname: Colijn, Caroline |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36962089$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUtvFDEQhC0URELIP0DIRy67-Dn25IYiHpFW4hK4Wj2eno0X73ixPaD8e2ayG4Q40Be3rK-qpaqX5GxMIxLymrM1l4a_26UpjxDXh-3hfs2WEewZuRCmMSspjT77az8nV6XsFsRyZlr5gpzLpm0Es-0F2XwD78OINKcY01RpqRkqbgOWa3p3j9RDQTqkTH8-glDDuKVYCo41QKS_Uv6OuVCEHB9ekecDxIJXp_eSfP344e7m82rz5dPtzfvNyiur66qFTvay1bY1QulGWW6tYkx71XHweugbpnzXa60NG0BZFH3HJDDBsVMcGnlJbo--fYKdO-Swh_zgEgT3-JHy1kGuwUd0vLeCcS5R90qZoet65LrlTPKGCWPF7PX26HXI6ceEpbp9KB5jhBHTVJww7ZL4HNiMvjmhU7fH_s_hpzRn4PoI-JxKyTg4H-qcWBrnUEN0nLnFy53ac0t77tTeLFb_iJ_8_yv7DdCnoJc |
| CitedBy_id | crossref_primary_10_1371_journal_pgph_0000486 crossref_primary_10_1038_s41598_023_43005_0 crossref_primary_10_1371_journal_pone_0264455 crossref_primary_10_1093_cid_ciac398 crossref_primary_10_3389_fpubh_2022_994206 crossref_primary_10_1016_j_jtbi_2022_111368 crossref_primary_10_1016_j_patter_2023_100739 crossref_primary_10_1016_j_orl_2024_107140 crossref_primary_10_1371_journal_pgph_0001204 crossref_primary_10_1080_02664763_2024_2440031 crossref_primary_10_1136_bmjopen_2022_061139 crossref_primary_10_1186_s12916_022_02641_5 crossref_primary_10_17269_s41997_024_00910_9 crossref_primary_10_1093_aje_kwad185 crossref_primary_10_1007_s11019_025_10261_y crossref_primary_10_1136_bmj_2023_075666 crossref_primary_10_1080_07853890_2022_2138960 crossref_primary_10_3934_mbe_2023249 |
| Cites_doi | 10.1001/archinternmed.2009.384 10.1038/d41586-020-02483-2 10.1016/S0140-6736(16)00562-6 10.1084/jem.20050828 10.15585/mmwr.mm6950e2 10.1016/S0140-6736(20)32661-1 10.1093/bmb/ldq033 10.1126/sciadv.abf1374 10.1177/0272989X98018002S09 10.1056/NEJMc2018688 10.1001/jamanetworkopen.2021.0830 10.1073/pnas.2025786118 |
| ContentType | Journal Article |
| Copyright | Copyright: © 2021 Mulberry et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| Copyright_xml | – notice: Copyright: © 2021 Mulberry et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| DBID | AAYXX CITATION NPM 7X8 DOA |
| DOI | 10.1371/journal.pgph.0000020 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic DOAJ Open Access Full Text |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 2767-3375 |
| ExternalDocumentID | oai_doaj_org_article_1d820113e5d447fbbde1591031602782 36962089 10_1371_journal_pgph_0000020 |
| Genre | Journal Article |
| GroupedDBID | 53G AAFWJ AAWOE AAYXX AFPKN ALMA_UNASSIGNED_HOLDINGS CITATION EIHBH FPL GROUPED_DOAJ M~E OK1 RPM NPM 7X8 |
| ID | FETCH-LOGICAL-c485t-9ab3d3958972456481884005c4b1ac5fd604cbd55570fa48e2db03a021eb41a63 |
| IEDL.DBID | DOA |
| ISSN | 2767-3375 |
| IngestDate | Wed Aug 27 01:31:33 EDT 2025 Fri Jul 11 11:25:18 EDT 2025 Thu Jan 02 22:52:35 EST 2025 Tue Jul 01 01:36:27 EDT 2025 Thu Apr 24 23:00:51 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Language | English |
| License | Copyright: © 2021 Mulberry et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c485t-9ab3d3958972456481884005c4b1ac5fd604cbd55570fa48e2db03a021eb41a63 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0001-6957-7236 0000-0001-5728-4129 0000-0001-6097-6708 0000-0002-4340-4481 0000-0002-1465-8001 |
| OpenAccessLink | https://doaj.org/article/1d820113e5d447fbbde1591031602782 |
| PMID | 36962089 |
| PQID | 2791371696 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_1d820113e5d447fbbde1591031602782 proquest_miscellaneous_2791371696 pubmed_primary_36962089 crossref_citationtrail_10_1371_journal_pgph_0000020 crossref_primary_10_1371_journal_pgph_0000020 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-10-13 |
| PublicationDateYYYYMMDD | 2021-10-13 |
| PublicationDate_xml | – month: 10 year: 2021 text: 2021-10-13 day: 13 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | PLOS global public health |
| PublicationTitleAlternate | PLOS Glob Public Health |
| PublicationYear | 2021 |
| Publisher | Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science (PLoS) |
| References | SE Oliver (pgph.0000020.ref003) 2020; 69 J Rodríguez (pgph.0000020.ref032) 2021 pgph.0000020.ref021 A Rao (pgph.0000020.ref045) 2021 INO Souza (pgph.0000020.ref025) 2019; 12 pgph.0000020.ref019 E Yong (pgph.0000020.ref014) 2020 CA Spencer (pgph.0000020.ref027) 2020 pgph.0000020.ref018 SJ Whitehead (pgph.0000020.ref038) 2010; 96 A Babus (pgph.0000020.ref034) 2020 M Taquet (pgph.0000020.ref023) 2021 M Voysey (pgph.0000020.ref004) 2021; 397 KRW Emary (pgph.0000020.ref010) 2021 S Mallapaty (pgph.0000020.ref013) 2020; 585 pgph.0000020.ref036 J Gu (pgph.0000020.ref024) 2005; 202 pgph.0000020.ref035 NL Washington (pgph.0000020.ref047) 2021 E Petter (pgph.0000020.ref011) 2021 M Levine-Tiefenbrun (pgph.0000020.ref012) 2021 J Mitnick (pgph.0000020.ref007) 2021 A Rismanbaf (pgph.0000020.ref022) 2020; 8 VM Cao-Lormeau (pgph.0000020.ref026) 2016; 387 C Zimmer (pgph.0000020.ref001) 2021 SL Caddy (pgph.0000020.ref005) 2021 LR Baden (pgph.0000020.ref002) 2020 J Chen (pgph.0000020.ref030) 2021 AA Stinnett (pgph.0000020.ref040) 1998; 18 PC Jentsch (pgph.0000020.ref031) 2021 pgph.0000020.ref044 pgph.0000020.ref046 pgph.0000020.ref041 pgph.0000020.ref043 (pgph.0000020.ref015) 2020; 586 pgph.0000020.ref042 pgph.0000020.ref037 VJ Hall (pgph.0000020.ref008) 2021 KA Brown (pgph.0000020.ref048) 2021 JK Logue (pgph.0000020.ref016) 2021; 4 MHB Lam (pgph.0000020.ref017) 2009; 169 JH Buckner (pgph.0000020.ref033) 2021; 118 pgph.0000020.ref050 F Rubino (pgph.0000020.ref020) 2020; 383 pgph.0000020.ref051 pgph.0000020.ref009 pgph.0000020.ref049 pgph.0000020.ref006 KM Bubar (pgph.0000020.ref028) 2021 L Matrajt (pgph.0000020.ref029) 2020; 7 AH Briggs (pgph.0000020.ref039) 2020 |
| References_xml | – year: 2021 ident: pgph.0000020.ref007 publication-title: A leaked report shows Pfizer’s vaccine is conquering covid-19 in its largest real-world test – year: 2021 ident: pgph.0000020.ref023 article-title: Six-month Neurological and Psychiatric Outcomes in 236,379 Survivors of COVID-19. publication-title: medRxiv – ident: pgph.0000020.ref018 – ident: pgph.0000020.ref037 – ident: pgph.0000020.ref046 – volume: 169 start-page: 2142 issue: 22 year: 2009 ident: pgph.0000020.ref017 article-title: Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up publication-title: Archives of internal medicine doi: 10.1001/archinternmed.2009.384 – volume: 585 start-page: 16 issue: 7823 year: 2020 ident: pgph.0000020.ref013 article-title: The coronavirus is most deadly if you are older and male—new data reveal the risks publication-title: Nature doi: 10.1038/d41586-020-02483-2 – year: 2021 ident: pgph.0000020.ref012 publication-title: Decreased SARSCoV-2 viral load following vaccination – year: 2020 ident: pgph.0000020.ref039 article-title: Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19 publication-title: Health Economics – ident: pgph.0000020.ref042 – year: 2021 ident: pgph.0000020.ref011 publication-title: Initial real world evidence for lower viral load of individuals who have been vaccinated by BNT162b2 – year: 2021 ident: pgph.0000020.ref008 publication-title: Effectiveness of BNT162b2 mRNA Vaccine Against Infection and COVID-19 Vaccine Coverage in Healthcare Workers in England, Multicentre Prospective Cohort Study (the SIREN Study) – year: 2021 ident: pgph.0000020.ref028 article-title: Model-informed COVID-19 vaccine prioritization strategies by age and serostatus publication-title: Science – ident: pgph.0000020.ref051 – year: 2021 ident: pgph.0000020.ref031 article-title: Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study publication-title: Lancet Infect Dis – volume: 387 start-page: 1531 issue: 10027 year: 2016 ident: pgph.0000020.ref026 article-title: Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study publication-title: Lancet doi: 10.1016/S0140-6736(16)00562-6 – ident: pgph.0000020.ref041 – year: 2020 ident: pgph.0000020.ref014 article-title: Long-Haulers Are Redefining COVID-19 publication-title: The Atlantic. – ident: pgph.0000020.ref049 – year: 2020 ident: pgph.0000020.ref027 article-title: ‘Long-haul’ covid-19 complications are real. I faced similar problems after surviving Ebola publication-title: The Washington Post – year: 2021 ident: pgph.0000020.ref030 article-title: Prioritizing allocation of COVID-19 vaccines based on social contacts increases vaccination effectiveness publication-title: medRxiv – volume: 202 start-page: 415 issue: 3 year: 2005 ident: pgph.0000020.ref024 article-title: Multiple organ infection and the pathogenesis of SARS publication-title: J Exp Med doi: 10.1084/jem.20050828 – volume: 69 start-page: 1922 issue: 50 year: 2020 ident: pgph.0000020.ref003 article-title: The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine—United States, December 2020 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm6950e2 – year: 2021 ident: pgph.0000020.ref005 article-title: Coronavirus: few vaccines prevent infection–here’s why that’s not a problem publication-title: The Conversation – ident: pgph.0000020.ref050 – ident: pgph.0000020.ref035 – year: 2020 ident: pgph.0000020.ref002 article-title: Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine publication-title: New England Journal of Medicine – volume: 397 start-page: 99 issue: 10269 year: 2021 ident: pgph.0000020.ref004 article-title: Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK publication-title: Lancet doi: 10.1016/S0140-6736(20)32661-1 – ident: pgph.0000020.ref021 – volume: 96 start-page: 5 year: 2010 ident: pgph.0000020.ref038 article-title: Health outcomes in economic evaluation: the QALY and utilities publication-title: Br Med Bull doi: 10.1093/bmb/ldq033 – volume: 7 issue: 6 year: 2020 ident: pgph.0000020.ref029 article-title: Vaccine optimization for COVID-19: Who to vaccinate first? publication-title: Sci Adv doi: 10.1126/sciadv.abf1374 – year: 2020 ident: pgph.0000020.ref034 publication-title: The Optimal Allocation of Covid-19 Vaccines – volume: 18 start-page: S68 issue: 2 Suppl year: 1998 ident: pgph.0000020.ref040 article-title: Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis publication-title: Med Decis Making doi: 10.1177/0272989X98018002S09 – ident: pgph.0000020.ref006 – year: 2021 ident: pgph.0000020.ref047 article-title: Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States publication-title: medRxiv – ident: pgph.0000020.ref044 – ident: pgph.0000020.ref009 – year: 2021 ident: pgph.0000020.ref010 publication-title: Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7) – volume: 586 issue: 170 year: 2020 ident: pgph.0000020.ref015 article-title: Long COVID: let patients help define long-lasting COVID symptoms publication-title: Nature – volume: 383 start-page: 789 issue: 8 year: 2020 ident: pgph.0000020.ref020 article-title: New-Onset Diabetes in Covid-19 publication-title: N Engl J Med doi: 10.1056/NEJMc2018688 – ident: pgph.0000020.ref019 – ident: pgph.0000020.ref036 – year: 2021 ident: pgph.0000020.ref001 article-title: Coronavirus Vaccine Tracker publication-title: The New York Times – year: 2021 ident: pgph.0000020.ref045 article-title: A disproportionate epidemic: COVID-19 cases and deaths among essential workers in Toronto, Canada publication-title: medRxiv – year: 2021 ident: pgph.0000020.ref032 article-title: COVID-19 vaccination rate and protection attitudes can determine the best prioritisation strategy to reduce fatalities publication-title: medRxiv – volume: 12 issue: 2 year: 2019 ident: pgph.0000020.ref025 article-title: Late Neurological Consequences of Zika Virus Infection: Risk Factors and Pharmaceutical Approaches publication-title: Pharmaceuticals – volume: 4 start-page: e210830 issue: 2 year: 2021 ident: pgph.0000020.ref016 article-title: Sequelae in Adults at 6 Months After COVID-19 Infection publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2021.0830 – volume: 118 issue: 16 year: 2021 ident: pgph.0000020.ref033 article-title: Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.2025786118 – volume: 8 start-page: e17 issue: 1 year: 2020 ident: pgph.0000020.ref022 article-title: Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor publication-title: Arch Acad Emerg Med – ident: pgph.0000020.ref043 – year: 2021 ident: pgph.0000020.ref048 publication-title: Rapid Rise of S-Gene Target Failure and the UK variant B.1.1.7 among COVID-19 isolates in the Greater Toronto Area, Canada |
| SSID | ssj0002810793 |
| Score | 2.3569016 |
| Snippet | In vaccination campaigns against COVID-19, many jurisdictions are using age-based rollout strategies, reflecting the much higher risk of severe outcomes of... |
| SourceID | doaj proquest pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source |
| StartPage | e0000020 |
| Title | Vaccine rollout strategies: The case for vaccinating essential workers early |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36962089 https://www.proquest.com/docview/2791371696 https://doaj.org/article/1d820113e5d447fbbde1591031602782 |
| Volume | 1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEA7SkyDi2_ooEbyuzTbJbuNNxVJEPVnpbclrFSnb0m79_c4k29KLePG6ZMkyM9lvkpl8HyHXLtU-T7VKBHdZImxmEsVUmajSSC5R3z1Uz19es-FIPI3leEPqC3vCIj1wNFw3dQGjuJdOiLw0xnlAYBQnyLBoFv6-TLGNzdRXODJKkfmtuSvH87TbuOZm9jH7jKSFKPG9gUWBsv_3PDPgzWCP7DaJIr2LH7hPtnx1QHbiKRuNl4cOyfO7tlgZp3Nw53RZ00W9on64pRAB1AJIUchL6XcYqLHJmSJdeAUre0KxKwvyP-qR5viIjAaPbw_DpNFHSKzoyzpR2nDHFVg0x_KlAOyF7RqTVphUW1m6jAlrnESWrVKLvu85w7gGVPdGpDrjx6RVTSt_SmAabZmXghtmAKEs5F3es9KmpTSlVbpN-MpShW3Iw1HDYlKEilgOm4holgLtWzT2bZNk_dYskmf8Mf4enbAei9TX4QEERNEERPFXQLTJ1cqFBSwVrH_oyk-Xi6KXK5w6U1mbnETfrqdCWcMe66uz__iEc7Ldw9YXbHzhF6RVz5f-EnKX2nRCmHbCodIPxRfsnA |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vaccine+rollout+strategies%3A+The+case+for+vaccinating+essential+workers+early&rft.jtitle=PLOS+global+public+health&rft.au=Mulberry%2C+Nicola&rft.au=Tupper%2C+Paul&rft.au=Kirwin%2C+Erin&rft.au=McCabe%2C+Christopher&rft.date=2021-10-13&rft.eissn=2767-3375&rft.volume=1&rft.issue=10&rft.spage=e0000020&rft_id=info:doi/10.1371%2Fjournal.pgph.0000020&rft_id=info%3Apmid%2F36962089&rft.externalDocID=36962089 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2767-3375&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2767-3375&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2767-3375&client=summon |